Designing Clinical Research and Interpreting Clinical Evidence - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

Designing Clinical Research and Interpreting Clinical Evidence

Description:

Objective of Using Clinical Evidence. To promote care based on best available evidence ... evaluating and incorporating evidence into daily clinical practice ... – PowerPoint PPT presentation

Number of Views:56
Avg rating:3.0/5.0
Slides: 20
Provided by: sonia6
Category:

less

Transcript and Presenter's Notes

Title: Designing Clinical Research and Interpreting Clinical Evidence


1
Designing Clinical Research and Interpreting
Clinical Evidence
  • Advances in Maternal and Neonatal Health

2
Objective of Using Clinical Evidence
  • To promote care based on best available evidence
  • To encourage practitioners to develop their
    skills in obtaining, evaluating and incorporating
    evidence into daily clinical practice
  • In order to achieve that, practitioners should
    understand and intellectually evaluate new
    clinical data as it becomes available

3
In an Ideal World
  • The most effective care for every condition would
    be known
  • Every clinician would know the most effective
    care for every patient
  • Every clinician would practice the most effective
    care that she/he knows

4
In the Real World
  • Much of what should be known is not known
  • Much that is known, is not known by most
    clinicians
  • Clinicians often fail to practice what they know
    to be the most effective form of care

5
  • Evidence-based medicine is the systematic,
    scientific and explicit use of current best
    evidence in making decisions about the care of
    individual patients.

6
Levels of Evidence and Grades of Recommendations

7
Conducting Research Steps
  • Formulate research question
  • Design study
  • Choose subjects
  • Choose variables to be measured
  • Collect data
  • Analyze data
  • Draw conclusions

8
Definitions
  • Quality of test
  • Sensitivity Likelihood that diagnostic test will
    indicate presence of disease when disease is
    actually present (true positive rate)
  • Specificity Likelihood that diagnostic test will
    indicate absence of disease when disease is
    actually absent
  • Usefulness of result
  • Positive predictive value Likelihood that
    positive test result actually means that disease
    is present
  • Negative predictive value Likelihood that
    negative test result actually mean that disease
    is absent

9
Prototype 2 X 2 Table
  • Example Doing a culture for Group B
    streptococcus (GBS)
  • Sensitivity Chance that test will indicate GBS
    when woman has it
  • Specificity Chance that test will indicate no
    GBS when woman does not have it
  • Positive predictive value Chance that positive
    culture GBS colonization
  • Negative predictive value Chance that negative
    culture no GBS

PPV
a b c d
- NPV
Spec.
Sens.
10
2 X 2 Table (continued)
Sensitivity 67 Specificity 52 PPV 20 NPV
90
11
Meta Analysis
  • Is one tool that may allow useful information to
    be obtained from multiple studies
  • Is systematic evaluation of collection of several
    studies which are similar in design, study
    populations and outcomes examined
  • Combines data appropriately to find answer to
    important question in cumulative information in
    literature
  • Is systematic review of medical literature

12
Measures of Statistical Significance Relative
Risk
  • Rate of risk of outcome in exposed individuals to
    risk in unexposed individuals
  • From cohort study only
  • Reflects risk to total population
  • Relative risk
  • 1 No difference in outcome between 2 groups
  • lt 1 Less risk of outcome
  • gt 1 Higher risk of outcome

13
Measures of Statistical Significance Odds Ratio
  • Compares likelihood of outcome being studied
    occurring in group receiving intervention
    (experimental) with group not receiving (control)
  • From case control
  • Does not reflect total population, but can
    closely estimate relative risk
  • Graphically represented on logarithmic scale
  • Vertical line at 1 No difference in outcome
    between two groups
  • Ratios less than 1 (left of vertical line)
    Improvement of outcome
  • Ratios more than 1 Worse outcome

14
Measures of Statistical Significance 95
Confidence Interval
  • Confidence interval Range in which true effect
    size can be found
  • 95 chance that true effect size lies within 95
    confidence interval
  • If confidence interval overlaps 1.0, then there
    is a gt 5 possibility that observed outcome
    difference is due to chance
  • Very wide results less believable
  • Very narrow more believable

15
Reduced Risk
Increased Risk
Confidence Interval
Results consistent with chance
0.01
0.1
1
10
100
Odds Ratio
No Difference
16
Measures of Statistical Significance p Value
  • The probability, under a null hypothesis, of data
    as extreme or more extreme than was observed in
    one study
  • Conventionally set as 0.05
  • Equivalent to 5
  • Difference is significant if p value is less than
    0.05 (lt 0.05)
  • Means that there is less than a 5 chance that
    the result obtained is due to chance, or
  • 95 certain that result obtained by the
    intervention is true

17
Statistical Significance vs. Clinical Significance
  • It is up to the practitioner to decide whether a
    statistically significant or non-significant
    result is clinically significant

18
Summary
  • Evidence-based medicine should be used to set a
    standard of care
  • New data should be evaluated critically to
    determine whether to change standards

19
References
  • Hulley SB and SR Cummings. 1988. Designing
    Clinical Research An epidemiological approach.
    Williams and Wilkins Baltimore, Maryland.
Write a Comment
User Comments (0)
About PowerShow.com